CDT Equity Inc. (CDT)Healthcare | Biotechnology | Naples, United States | NasdaqCM
1.69 USD
-0.19
(-10.106%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 1.68 -0.01 (-0.010%) ⇩ (Aug. 28, 2026, 7:37 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 5:42 a.m. EDT
The immediate outlook remains deeply bearish due to a catastrophic collapse in share price, which has erased nearly 99.99% of the company's value over the last three years. While recent headlines celebrate a patent win and a debt cleanup, these developments have failed to arrest the bleeding, leaving the stock trading at a fraction of its book value with no credible path to recovery in the near term. The recent price action shows a volatile but generally downward drift, confirming that the market views these operational updates as insufficient to reverse the structural damage. For the long term, the investment case is effectively broken; the company is hemorrhaging equity value with negative returns on assets and equity, and the massive price drop suggests the market has already priced out any hope of the business model working as intended. There is no dividend to provide income, and the capital structure is precarious with debt exceeding cash reserves. This is a classic value trap where the low price reflects a deteriorating business rather than a bargain. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 1.524559 |
| MSTL | 1.632781 |
| AutoETS | 1.666780 |
| AutoARIMA | 1.670447 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 16% |
| H-stat | 66.55 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.036 |
| Excess Kurtosis | -1.86 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.147 |
| Market Cap | 1,329,472 |
| Beta | 1.49 |
| Previous Name | Conduit Pharmaceuticals Inc. |
| Website | https://www.cdtequity.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.9992932 |
| Address1 | 4,581 Tamiami Trail North |
| Address2 | Suite 200 |
| All Time High | 75,000,000.0 |
| All Time Low | 1.8 |
| Ask | 2.24 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 102,770 |
| Average Daily Volume3 Month | 665,458 |
| Average Volume | 665,458 |
| Average Volume10Days | 102,770 |
| Beta | 1.487 |
| Bid | 1.43 |
| Bid Size | 2 |
| Book Value | 163.36 |
| City | Naples |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.69 |
| Current Ratio | 0.126 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 2.03 |
| Day Low | 1.62 |
| Debt To Equity | 1.147 |
| Display Name | CDT Equity |
| Earnings Timestamp End | 1,762,977,600 |
| Earnings Timestamp Start | 1,762,977,600 |
| Ebitda | -22,833,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.077 |
| Enterprise Value | 1,764,472 |
| Eps Trailing Twelve Months | -3,050.69 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 4.26638 |
| Fifty Day Average Change | -2.5763798 |
| Fifty Day Average Change Percent | -0.60387963 |
| Fifty Two Week Change Percent | -99.92932 |
| Fifty Two Week High | 2,720.0 |
| Fifty Two Week High Change | -2,718.31 |
| Fifty Two Week High Change Percent | -0.9993787 |
| Fifty Two Week Low | 1.62 |
| Fifty Two Week Low Change | 0.07000005 |
| Fifty Two Week Low Change Percent | 0.04320991 |
| Fifty Two Week Range | 1.62 - 2720.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,648,474,200,000 |
| Float Shares | 758,948 |
| Free Cashflow | 19,616,876 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 4 |
| Fullday Change | -0.19 |
| Fullday Change Percent | -10.1064 |
| Fullday Price | 1.68 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.22941 |
| Held Percent Institutions | 0.02155 |
| Implied Shares Outstanding | 786,670 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,784,505,600 |
| Last Split Factor | 1:10 |
| Long Business Summary | CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida. |
| Long Name | CDT Equity Inc. |
| Market | us_market |
| Market Cap | 1,329,472 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1772079937 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-08-28 |
| Net Income To Common | -37,147,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,478,939 |
| Open | 1.98 |
| Operating Cashflow | -11,484,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 646 491 9132 |
| Post Market Change | -0.01000011 |
| Post Market Change Percent | -0.5917224 |
| Post Market Price | 1.68 |
| Post Market Time | 1,787,960,222 |
| Prev Name | Conduit Pharmaceuticals Inc. |
| Previous Close | 1.88 |
| Price Hint | 4 |
| Price To Book | 0.01034525 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.039 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.19 |
| Regular Market Change Percent | -10.1064 |
| Regular Market Day High | 2.03 |
| Regular Market Day Low | 1.62 |
| Regular Market Day Range | 1.62 - 2.03 |
| Regular Market Open | 1.98 |
| Regular Market Previous Close | 1.88 |
| Regular Market Price | 1.69 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 484,288 |
| Return On Assets | -0.23435 |
| Return On Equity | -0.6968 |
| Sand P52 Week Change | 0.1966995 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 786,670 |
| Shares Percent Shares Out | 0.0127 |
| Shares Short | 9,954 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 18,533 |
| Short Name | CDT Equity Inc. |
| Short Percent Of Float | 0.0179 |
| Short Ratio | 0.13 |
| Source Interval | 15 |
| State | FL |
| Symbol | CDT |
| Total Cash | 747,000 |
| Total Cash Per Share | 0.95 |
| Total Debt | 1,182,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3,050.69 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 160.51619 |
| Two Hundred Day Average Change | -158.82619 |
| Two Hundred Day Average Change Percent | -0.98947144 |
| Type Disp | Equity |
| Volume | 484,288 |
| Website | https://www.cdtequity.com |
| Zip | 34,103 |